Development of new human papillomavirus vaccines;Desarrollo de nuevas vacunas frente al virus del papiloma humano

Piel

Volumn 22, Issue 2, 2007, Pages 51-53

  Rodríguez Cerdeira, Carmen ^a   Alba Menéndez, Alfonso ^b   Vilata Corella, Juan José ^a  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b Instituto de Estudios Celulares Y Moleculares de Galicia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

EDITORIAL; HUMAN; PROPHYLAXIS; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

EID: 34547918848     PISSN: 02139251     EISSN: 15788830     Source Type: Journal    
DOI: 10.1016/S0213-9251(07)73014-9     Document Type: Editorial

References (20)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worlwide. J Pathol. 1999;189:12-6.
2. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.
3. Goldie SJ, Goldhaber-Fiebert JD, Garnett GP. Chapter 18: public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling. Vaccine. 2006;24:S155-63.
4. Goldie SJ, Kim JJ, Myers E. Chapter 19: Cost-effectiveness of cervical screening. Vaccine. 2006;24:S164-70.
5. Adams M, Borysiewicz L, Fiander A, Man S, Jasani B, Navabi H, et al. Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine. 2001;19:2549-56.
6. Stanley MA. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection. Expert Rev Vaccines. 2003;2:381-9.
7. Baldwin PJ, Van der Burg SH, Boswell CM, Offrienge R, Hickling JK, Dobson J, et al. Vaccinia-expresed human papillomavirus 16 and 18 E6 and E7 as a therapeutic vaccination for vulvar and vaginal intraepithelial neoplasia. Clin Cancer Res. 2003;9:5205-13.
8. Kirnbauer R, Booy F, Cheng N, Lowy DR, Shiller JT. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences of the United States of America. Proc Natl Acad Sci USA. 1992;89:12180-4.
9. Foerster V, Murtagh J. Vaccines for prevention of human papillomavirus infection. Issues Emerg Health Technol. 2005;75:1-4.
10. Stanley MA. Human papillomavirus vaccines. Rev Med Virol. 2006;16:139-49.
11. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Álvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002;347:1645-51.
12. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004;364:1757-65.
13. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giulando AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentric phase II efficacy trial. Lancet Oncol. 2005;6:271-8.
14. Schmiedeskamp MR, Kockler DR. Human papillomavirus vaccines. Ann Pharmacother. 2006;40:1344-52.
15. Shaw AR. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Gynecol Oncol. 2005;99:S246-8.
16. Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005;37:S17-23.
17. Steinbrook R. The potential of human papillomavirus vaccines. N Engl J Med. 2006;354:1109-12.
18. Committee on Adolescent Health Care; ACOG Committee Opinion No. 344: Human papillomavirus vaccination. Obstet Gynecol. 2006;108:699-705.
19. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
20. Kahn JA. Vaccination as a prevention strategy for human papillomavirus-related diseases. J Adolesc Health. 2005;37:S10-6.